A novel lamin A/C gene mutation causing spinal muscular atrophy phenotype with cardiac involvement: report of one

Naotoshi Iwahara1, Shin Hisahara2, Takashi Hayashi3,4

  • 1Department of Neurology, School of Medicine, Sapporo Medical University, South 1 West 16, Chuo-ku, Sapporo, 060-8543, Japan. n.iwahara@sapmed.ac.jp.

BMC Neurology
|April 18, 2015
PubMed

Insights

Lamin A/C gene mutations can cause spinal muscular atrophy (SMA) and cardiac issues. This study details a Japanese patient with SMA phenotype and cardiac disease, highlighting the importance of lamin A/C gene analysis.

Area of Science:

  • Genetics
  • Neurology
  • Cardiology

Background:

  • Mutations in the lamin A/C gene are linked to various diseases, termed laminopathies, including muscular dystrophies and cardiomyopathies.
  • While rare, a connection between lamin A/C mutations and spinal muscular atrophy (SMA) with cardiomyopathy has been suggested but not firmly established.

Observation:

  • A 65-year-old Japanese male presented with lower limb amyotrophy, gait disturbance since childhood, and cardiac dysfunction.
  • Neurological and electrophysiological evaluations indicated spinal muscular atrophy type 3.
  • Genetic analysis revealed a novel nonsense mutation (p.Q353X) in the lamin A/C gene in the patient and his family, who also exhibited cardiac conditions like atrioventricular block.

Findings:

  • This case represents the first documented instance of a spinal muscular atrophy phenotype associated with a lamin A/C gene mutation in a Japanese individual.
  • The identified mutation, p.Q353X, provides further evidence for the role of lamin A/C gene defects in SMA.

Implications:

  • The findings suggest that lamin A/C gene analysis should be considered in patients presenting with an SMA phenotype, particularly when accompanied by unexplained cardiac disease and a positive family history.
  • This broadens the diagnostic considerations for laminopathies and emphasizes the genotype-phenotype correlation within these genetic disorders.
Abstract

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
125.6K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K